When a child has spasticity in all four limbs, oral medication often comes with a trade-off. The dose that finally loosens tight muscles may also leave a child too drowsy to get through a school day or a therapy session.
An intrathecal baclofen pump is one answer to that problem. Instead of sending baclofen through the bloodstream, a small implanted pump delivers it directly into the fluid around the spinal cord, where it reaches the nerves that drive muscle tone. A critical review published in the Journal of Clinical Medicine on May 25, 2026 gathered what is now known about how the therapy performs in children with cerebral palsy.
The results are encouraging, but should be considered along with the risks. These devices can provide real and lasting tone relief. Gains in gross motor function are far less predictable. However, the surgery carries a complication rate that families should be aware of before they consent, not after.
“A baclofen pump is very good at one job: lowering muscle tone and keeping it low. Whether that turns into new movement depends on where a child starts and what the team sets out to achieve.”
— Cerebral Palsy Center Editorial Team
What do IB Pumps actually do?
Baclofen calms muscles by acting on GABA-B receptors in the spinal cord and brainstem. Swallowed as a tablet, it has to cross the blood-brain barrier to get there, which means dosing the whole body to treat one part of it. That is where the sedation, and often the nausea and weakness, come from.
Intrathecal delivery skips that step. A pump roughly the size of a hockey puck is placed under the skin of the abdomen, and a thin catheter carries the drug into the intrathecal space around the spinal cord. Because the medication arrives where it is needed, the dose required is a small fraction of an oral prescription, and the systemic side effects largely fall away.
The pump is refilled on a schedule set by the care team, and it is replaced when the battery reaches the end of its life. This is an ongoing relationship with a clinic, not a one-time operation.
Findings from the 2026 review of IB pumps
The recent Journal of Clinical Medicine review describes intrathecal baclofen as an established option for severe generalized spasticity. This is specifically true when rehabilitation, oral medication, and focal treatments like botulinum toxin injections haven't been enough or weren't tolerated. This means it isn't considered a first step treatment.
On tone, the evidence is consistent. The authors report substantial and sustained reduction in muscle tone, along with improvements in comfort, positioning, ease of care, pain, and selected quality-of-life measures. For a family whose mornings revolve around a painful, difficult dressing and transfer routine, those are meaningful outcomes.
On movement, the evidence is mixed. Gains in gross motor function varied and depended on the child’s baseline motor pattern, on goals set for that individual child, and on careful dose adjustment over time. In practice this means the honest goal for a child at GMFCS Level IV or V is usually comfort, easier caregiving, better seating, and less pain, rather than walking.
A complication rate families must consider
A systematic review and meta-analysis in BMC Neurology looked at 501 pump implantations and recorded 203 medical complications. Among those complications were 33 infections, 16 cerebrospinal fluid leaks, eight cases of meningitis, seven cases of increased seizure frequency, and six new-onset seizures.
Infection is the headline risk. Pump surgery carries one of the highest surgical site infection rates in medicine, which is why the Cerebral Palsy Research Network ran a multicenter quality improvement project across participating centers specifically to bring that rate down. The fact that a national network built a project around this problem tells you how concerning it is.
None of this means the therapy is a bad choice. The same analyses that count these complications also conclude that the effect on spasticity is significant. It means the decision is a genuine weighing of benefit against risk, and it should be made with your child's unique situation in mind.
Questions to ask before deciding on an IB ump
- What is the specific goal? Ask the team to name it in plain words: less pain, easier transfers, better sitting tolerance, fewer hours of stretching. A goal you can recognize six months later is a goal you can evaluate.
- Will there be a trial dose first? A screening dose before implantation is standard practice and shows whether a child responds.
- How many pumps does this center place each year, and what is its infection rate? Volume and infection tracking are fair questions, and a center that measures its own rate is usually a center working to lower it.
- What are the warning signs of withdrawal, and who do we call? If a catheter kinks or a pump fails, the medication stops. Know the symptoms and the number before you go home.
- How far is the refill clinic, and how often will we be there? Refills are the part of this therapy that will be part of your calendar for years.
If your child’s spasticity is focal rather than generalized, a different conversation may fit better. Our overview of medications used in cerebral palsy covers where oral and injected options fit.
